http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20120120524-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-465 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7084 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-465 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 |
| filingDate | 2011-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20120120524-A |
| titleOfInvention | Percutaneous Absorption Formulation and Manufacturing Method Thereof |
| abstract | The present invention relates to transdermal absorbent preparations and methods for their preparation. In the percutaneous absorption preparation of the present invention, a drug-containing layer containing a drug is present, and a drug protective layer made of a non-invasive material is positioned above the drug-containing layer, and a lower portion thereof controls the release of the drug during permeation. Emission control adhesive layer having a position is made to include them. The percutaneous absorbent preparation of the present invention is prepared by including a drug-containing layer as a drug reservoir that can prevent the loss of the drug during the process or storage of the product and the release of the drug and a release-controlled adhesive layer having the function of a release-controlling membrane. It is effective in preventing loss and controlling skin permeation of drugs. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110475548-A |
| priorityDate | 2011-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 28.